Prabhudas Lilladher recommended hold rating on Indoco Remedies with a target price of Rs 325 in its research report dated July 25, 2025.
Prabhudas Lilladher recommended hold rating on Indoco Remedies with a target price of Rs 325 in its research report dated January 22, 2025.
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 320 in its research report dated October 24, 2024.
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 320 in its research report dated July 25, 2024.
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 380 in its research report dated January 24, 2024.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 385 in its research report dated October 19, 2023.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 380 in its research report dated July 25, 2023.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 400 in its research report dated May 24, 2023.
ICICI Direct is bullish on Indoco Remedies recommended buy rating on the stock with a target price of Rs 440 in its research report dated January 25, 2023.
ICICI Direct is bullish on Indoco Remedies recommended buy rating on the stock with a target price of Rs 465 in its research report dated November 13, 2022.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 430 in its research report dated November 14, 2022.
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 525 in its research report dated August 10, 2022.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 430 in its research report dated August 09, 2022.
YES Securities is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 500 in its research report date May 17, 2022.
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 510 in its research report dated May 18, 2022.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 430 in its research report dated May 17, 2022.
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 460 in its research report dated February 03, 2022.
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 510 in its research report dated February 03, 2021.
Prabhudas Lilladher recommended accumulate rating on Indoco Remedies with a target price of Rs 480 in its research report dated November 04, 2021.
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 575 in its research report dated August 12, 2021.
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 390 in its research report dated May 26, 2021.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 358 in its research report dated February 10, 2021.
ICICI Securities is bullish on Indoco Remedies recommended buy rating on the stock with a target price of Rs 380 in its research report dated December 30, 2020.
Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 352 in its research report dated November 09, 2020.
ICICI Direct is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 335 in its research report dated November 06, 2020.